# US 2018/0023090 A1 · Methods for plant transformation using spectinomycin selection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0023090 A1
- Document ID: US20180023090A1
- Status: Published application
- Kind: A1
- Application number: 15/638,200
- Filed: 2017-06-29
- Published: 2018-01-25
- Earliest claimed: 2007-03-09
- Assignees: Monsanto Technology LLC
- Applicants: Monsanto Technology LLC
- Inventors: Brian J. Martinell; Michael W. Petersen; David A. Somers; Yuechun Wan; Edward Williams; Xudong Ye
- Web page: https://patentgrep.com/patent/US20180023090A1

## CPC

- C12N 15/8209: {Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers}
- A01H 4/003: {Cutting apparatus specially adapted for tissue culture}
- A01H 4/008: {Methods for regeneration to complete plants}
- C12N 5/0025: {Culture media for plant cell or plant tissue culture}
- C12N 5/04: Plant cells or tissues {(culture media C12N5/0025)}
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 15/8201: {Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation}
- C12N 15/8202: {by biological means, e.g. cell mediated or natural vector}
- C12N 15/8205: {Agrobacterium mediated transformation}
- C12N 15/8221: {Transit peptides}
- C12N 15/8265: {Transgene containment, e.g. gene dispersal}
- C12N 15/8271: {for stress resistance, e.g. heavy metal resistance}
- C12N 15/8274: {for herbicide resistance}
- C12N 15/8275: {Glyphosate}
- C12N 15/8277: {Phosphinotricin}
- C12N 15/8281: {for bacterial resistance}
- G01N 33/0098: {Plants or trees (wood G01N33/46)}
- A01H 6/202: {Brassica napus [canola]}
- A01H 6/4684: {Zea mays [maize]}
- A01H 6/542: {Glycine max [soybean]}
- A01H 6/604: {Gossypium [cotton]}
- C12N 1/205: Bacterial isolates
- C12N 15/8261: {with agronomic (input) traits, e.g. crop yield}
- C12R 2001/41: Rhizobium
- C12Y 203/01081: Aminoglycoside N3'-acetyltransferase (2.3.1.81)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01H: NEW PLANTS OR {NON-TRANSGENIC} PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12Y: ENZYMES

## Abstract

The present invention relates to methods and compositions for transforming soybean, corn, cotton, or canola explants using spectinomycin as a selective agent for transformation of the explants. The method may further comprise treatment of the explants with cytokinin during the transformation and regeneration process.

## Claims

### Claim at position 1

-5. (canceled)

### Claim 6

A method of producing a transgenic plant comprising:
(a) transforming at least a first seed explant with a heterologous nucleic acid sequence comprising a selectable marker conferring tolerance to spectinomycin; and
(b) regenerating a transgenic plant from the transformed cells, wherein the explant is contacted, prior to, concurrently with, and/or following step (a) or step (b), with at least a first media comprising spectinomycin to select transformed cells comprising said selectable marker.

### Claim at position 3

-8. (canceled)

### Claim 10 (depends on 6)

The method of claim 6, wherein the first seed explant comprises a transgene.

### Claim 11 (depends on 6)

The method of claim 6, wherein the explant is stored at a temperature of between 0-15° C. for between 1 hour and 7 days prior to step (a).

### Claim 12 (depends on 6)

The method of claim 6, wherein the explant comprises an embryonic meristem.

### Claim 13 (depends on 6)

The method of claim 6, wherein the media comprises from about 15 mg/L to about 1500 mg/L spectinomycin.

### Claim 14 (depends on 6)

The method of claim 6, wherein the cells of the explant comprise a coding sequence conferring tolerance to glyphosate, bialaphos, phosphinothricin, Basta, glufosinate, 2,4-D, kanamycin and related aminoglycosides, hygromycin, streptomycin, ampicillin, or dicamba.

### Claim 15 (depends on 6)

The method of claim 6, wherein during or following step (a), explants are grown in the presence of a selective agent at 35° C-40° C. and/or are grown under lighting conditions that allow for normal plastid development.

### Claim 16 (depends on 15)

The method of claim 15, wherein growth at 35° -40° C. is performed for 1-7 days or the lighting conditions comprise at least 5 μEinsteins with about a 16 hour light/8 dark photoperiod.

### Claim 17 (depends on 6)

The method of claim 6 wherein step (a) comprises growing an explant on a co-culture medium comprising spectinomycin.

### Claim 18 (depends on 17)

The method of claim 17, wherein the explant is not contacted with a medium comprising spectinomycin after being transferred from a co-culture medium.

### Claim 19 (depends on 17)

The method of claim 17, wherein the explant is contacted with a medium comprising spectinomycin after being transferred from a co-culture medium.

### Claim 20 (depends on 6)

The method of claim 6, wherein the explant that is regenerating into a plant is transferred to soil or soil substitute for rooting without pre-rooting in aseptic media.

### Claim 21 (depends on 6)

The method of claim 6, wherein the heterologous nucleic acid further comprises a coding sequence that confers a trait of agronomic interest or improved end use.

### Claim 22 (depends on 6)

The method of claim 6, wherein step (a) comprises transforming the cell of the explant with at least a second heterologous nucleic acid.

### Claim 23 (depends on 22)

The method of claim 22, wherein the second heterologous nucleic acid comprises a coding sequence that confers herbicide tolerance.

### Claim 24 (depends on 22)

The method of claim 22, wherein the first and second heterologous nucleic acids are integrated at different loci within the genome of the cell.

### Claim 25 (depends on 6)

The method of claim 6, further comprising, prior to step (a), the step of priming the seed, wherein the priming comprises contacting the seed with a cytokinin.

### Claim 26 (depends on 6)

The method of claim 6, further comprising contacting the explant with a cytokinin prior to, concurrently with and/or following step (b).

### Claim 27 (depends on 26)

The method of claim 26 wherein the cytokinin is selected from the group consisting of thidiazuron, BAP (6-Benzylaminopurine), kinetin, CPPU (N-(2-Chloro-4-pyridyl)-N′-phenylurea), 2iP (6-(y,y-Dimethylallylamino) purine), Zeatin, Zeatin-riboside, Adenine, and TIBA (2,3,5-Triiodobenzoic acid).

### Claim 28 (depends on 6)

The method of claim 6, wherein step (a) comprises contacting the explant with recombinant Rhizobiaceae comprising said heterologous nucleic acid, wherein the Rhizobiaceae have been exposed to thidiazuron prior to or concurrently with contacting the explant with the recombinant Rhizobiaceae.

### Claim 29 (depends on 28)

The method of claim 28, wherein the Rhizobiaceae is exposed to thidiazuron for from about 1 to 5 days prior to contacting the explant with the recombinant Rhizobiaceae.

### Claim 30 (depends on 28)

The method of claim 28, wherein the Rhizobiaceae are suspended in the presence of a selective agent active against an untransformed explant prior to contacting the explants with the Rhizobiaceae.

### Claim 31 (depends on 28)

The method of claim 28, wherein the Rhizobiaceae are selected from the group consisting of: Agrobacteria, Sinorhizobia, Mesorhizobia, and Rhizobia.

### Claim 32 (depends on 28)

The method of claim 28, wherein the explants are grown in the presence of a fungicide prior to, during, or subsequent to step (a).

### Claim 33 (depends on 32)

The method of claim 32, wherein the explants are grown in the presence of a fungicide and DMSO.

### Claim 34 (depends on 33)

The method of claim 33, wherein the explants are grown in the presence of nystatin, thiabendazole, and DMSO.

### Claim 35 (depends on 6)

The method of claim 6, wherein the explant is a soybean, corn, cotton, or canola explant.

### Claim 36 (depends on 35)

The method of claim 35, wherein the explant is a soybean explant.

### Claim 37 (depends on 6)

The method of claim 6, further comprising the step of
(c) obtaining a progeny plant of any generation of the transgenic plant that comprises the gene conferring the trait of interest and lacks the selectable marker.

### Claim 38 (depends on 6)

The method of claim 6, wherein the heterologous nucleic acid comprises a first DNA segment comprising left and right T-DNA borders flanking a gene conferring a trait of interest; and a second DNA segment comprising a second set of left and right T-DNA borders flanking said selectable marker conferring tolerance to spectinomycin.

### Claim 39 (depends on 38)

The method of claim 38, further comprising the step of
(c) obtaining a progeny plant of any generation of the transgenic plant that comprises the gene conferring the trait of interest and lacks the selectable marker.

### Claim 40 (depends on 6)

The method of claim 6, wherein the heterologous nucleic acid comprises right and left T-DNA borders and first and second DNA segments, wherein the first DNA segment comprises a gene of interest located after the right border, and wherein the second DNA segment comprises the selectable marker located after the left border.

### Claim 41 (depends on 6)

The method of claim 6, wherein the heterologous nucleic acid comprises first and second right T-DNA borders, wherein a first DNA segment comprising a gene of interest is located after the first right border and a second DNA segment comprising the selectable marker is located after the second right border.

### Claim 42 (depends on 6)

The method of claim 6, comprising culturing said explant on media lacking spectinomycin for from about 1 to about 7 days during step (b).

### Claim 43 (depends on 6)

The method of claim 6, wherein contacting the explant with at least a first media comprising spectinomycin is for from about 15 minutes to about 7 days.

### Claim 44 (depends on 6)

The method of claim 6, wherein the selectable marker is encoded by aadA.

### Claim 45 (depends on 44)

The method of claim 44, wherein aadA comprises SEQ ID NO:1.

### Claim 46 (depends on 44)

The method of claim 44, wherein the aadA gene is fused to a chloroplast transit peptide.

### Claim 47 (depends on 44)

The method of claim 44, wherein aadA comprises SEQ ID NO:2.

### Claim 48 (depends on 6)

The method of claim 6, wherein the explant is further defined as having been maintained prior to step (b) under conditions wherein the explant does not germinate and remains viable and competent for genetic transformation.

### Claim 49 (depends on 48)

The method of claim 48, wherein said conditions comprise dehydrating the explant or a seed comprising the explant.

### Claim 50 (depends on 49)

The method of claim 49, further defined as comprising increasing the moisture content of the explant prior to or concurrently with step (b).

### Claim 51 (depends on 48)

The method of claim 48, wherein said conditions comprise an internal moisture content of the explant of from about 3% to about 25%.

### Claim 52 (depends on 51)

The method of claim 51, wherein said conditions comprise an internal moisture content of the explant of from about 3% to about 16%.

### Claim 53 (depends on 48)

The method of claim 48, wherein said conditions comprise a temperature of between about −80° C. and about 60° C.

### Claim 54 (depends on 48)

The method of claim 48, further defined as comprising priming the explant prior to step (b).

### Claim 55 (depends on 54)

The method of claim 54, wherein priming the seed comprises contacting the explant or a seed comprising the explant with an aqueous solution comprising water, a plant growth regulator, a selection agent, or a cell membrane conditioner.

### Claim 56 (depends on 6)

The method of claim 6, wherein transforming at least a first cell of the explant with a heterologous nucleic acid is carried out by bacterially-mediated transformation or microprojectile bombardment.

### Claim 57 (depends on 6)

The method of claim 6, wherein the explant is further defined as having been excised from a seed comprising 3% to 25% internal moisture content, or a hydrated or germinating seed comprising 26% to 80% internal moisture content, or comprises a tissue of the group consisting of: meristem, immature embryo, embryo, embryonic axis, cotyledon, hypocotyl, mesocotyl, leaf, primary leaf base, leaf disc, shoot tip, and plumule.

### Claim 58 (depends on 57)

The method of claim 57, wherein the explant is further defined as having been excised from a germinated or imbibed seed.

### Claim 59 (depends on 6)

The method of claim 6, wherein the explant is not contacted with a media comprising spectinomycin subsequent to step (a).

### Claim 60 (depends on 6)

The method of claim 6, wherein the first media is a liquid.

### Claim 61 (depends on 6)

The method of claim 6, wherein one or more of steps (a)-(b) are automated.

### Claim at position 56

-64. (canceled)
